Matthew E. Levison
Impact in
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 0.1%
- Antimicrobial Resistance in Staphylococcus
Papers in
- Epidemiology 66
- Infective Endocarditis Diagnosis and Management 31
- Urinary Tract Infections Management 21
-
- Antimicrobial Resistance in Staphylococcus 35
- Co-authors
- Ann F. Bolger (19 shared papers)Kathryn A. Taubert (20 shared papers)Michael H. Gewitz (19 shared papers)Larry M. Baddour (13 shared papers)Jane W. Newburger (18 shared papers)Donald Kaye (45 shared papers)Walter R. Wilson (11 shared papers)Stanford T. Shulman (14 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (32 papers)The Journal of Infectious Diseases (13 papers)Circulation (12 papers)Clinical Infectious Diseases (7 papers)Current Infectious Disease Reports (6 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Matthew E. Levison
140 papers receiving 13.9k citations
Matthew E. Levison's Hit Papers
Peers
Comparison fields: 5 of 177
- Clinical Biochemistry 1.7k
- Infectious Diseases 4.3k
- Periodontics 1.0k
- Epidemiology 7.2k
- Molecular Medicine 944
Countries citing papers authored by Matthew E. Levison
This map shows the geographic impact of Matthew E. Levison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Levison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Levison more than expected).
Fields of papers citing papers by Matthew E. Levison
This network shows the impact of papers produced by Matthew E. Levison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Levison. The network helps show where Matthew E. Levison may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Levison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications Hit paper breakdown → | 2015 | 1919 |
| 2 | Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease Hit paper breakdown → | 2004 | 1361 |
| 3 | Infective Endocarditis Hit paper breakdown → | 2005 | 1204 |
| 4 | Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Hit paper breakdown → | 2004 | 990 |
| 5 | Prevention of bacterial endocarditis. Recommendations by the American Heart Association Hit paper breakdown → | 1997 | 776 |
| 6 | Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association? Hit paper breakdown → | 2012 | 770 |
| 7 | Update on Cardiovascular Implantable Electronic Device Infections and Their Management Hit paper breakdown → | 2010 | 700 |
| 8 | 1998 | 463 | |
| 9 | 1998 | 434 | |
| 10 | 1992 | 413 | |
| 11 | 2009 | 400 | |
| 12 | 2003 | 307 | |
| 13 | Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association Hit paper breakdown → | 2016 | 302 |
| 14 | 1997 | 240 | |
| 15 | 2004 | 208 | |
| 16 | 1981 | 196 | |
| 17 | 2002 | 176 | |
| 18 | 1986 | 153 | |
| 19 | 2000 | 153 | |
| 20 | 1983 | 134 |
About Matthew E. Levison
Matthew E. Levison is a scholar working on Epidemiology, Infectious Diseases, Pharmacology, Molecular Medicine and Clinical Biochemistry, having authored 141 papers that have together received 14.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (40 papers), Antimicrobial Resistance in Staphylococcus (35 papers), Antibiotic Resistance in Bacteria (35 papers), Infective Endocarditis Diagnosis and Management (31 papers), Bacterial Identification and Susceptibility Testing (26 papers), Urinary Tract Infections Management (21 papers), Streptococcal Infections and Treatments (21 papers) and Reproductive tract infections research (9 papers). The work is most often cited by research in Clinical Biochemistry (1.7k citations), Infectious Diseases (4.3k citations), Periodontics (1.0k citations), Epidemiology (7.2k citations) and Molecular Medicine (944 citations). Matthew E. Levison has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Ann F. Bolger, Kathryn A. Taubert, Michael H. Gewitz, Larry M. Baddour, Jane W. Newburger, Donald Kaye, Walter R. Wilson, Stanford T. Shulman, Robert S. Baltimore and Thomas J. Pallasch. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Circulation, Clinical Infectious Diseases and Current Infectious Disease Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.